James River Group Holdings, Ltd. ("James River" or the "Company")
(NASDAQ: JRVR) reported net income from continuing operations
available to common shareholders of $9.0 million ($0.18 per diluted
share) and adjusted net operating income1 of $9.1 million ($0.19
per diluted share) for the first quarter of 2025.
|
Three Months EndedMarch 31, |
|
Three Months EndedMarch 31, |
($ in thousands,
except for share data) |
|
2025 |
|
|
per diluted share |
|
|
2024 |
|
|
per dilutedshare |
Net income from continuing operations available to common
shareholders |
$ |
9,019 |
|
|
$ |
0.18 |
|
|
$ |
20,883 |
|
|
$ |
0.53 |
|
Net loss from discontinued
operations2 |
|
(1,414 |
) |
|
$ |
(0.02 |
) |
|
|
(8,105 |
) |
|
$ |
(0.18 |
) |
Net income available to common
shareholders |
|
7,605 |
|
|
$ |
0.16 |
|
|
|
12,778 |
|
|
$ |
0.35 |
|
Adjusted net operating
income1 |
|
9,102 |
|
|
$ |
0.19 |
|
|
|
14,832 |
|
|
$ |
0.39 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unless specified otherwise, all underwriting
performance ratios presented herein are for our continuing
operations and business not subject to retroactive reinsurance
accounting.
First Quarter 2025 Highlights:
- Annualized
adjusted net operating return on tangible common equity1 of 11.5%
and year to date growth in tangible common equity1 of 7.1%.
- E&S segment
combined ratio of 91.5% and renewal rate change of 7.8%, with the
majority of underwriting divisions reporting pricing
increases.
- Specialty
Admitted Insurance segment combined ratio of 102.1%, with fronting
and program gross written premium declining 21.3%.
- De minimis
overall prior year reserve activity. Group combined ratio of
99.5%.
- Final
independent accounting firm determination in the purchase price
adjustment dispute related to the sale of JRG Reinsurance Company
Ltd. (“JRG Re”), finding in favor of the Company on $53.6 million
of the aggregate $54.1 million of items in dispute, resulting in a
small downward adjustment to the purchase price of ($0.5) million.
This is reflected in the first quarter results.
Frank D'Orazio, the Company’s Chief Executive
Officer, commented on the first quarter, “Coming out of 2024, our
first quarter results show progress in strengthening our
underwriting performance and positioning the franchise for
long-term, sustainable profitability. Our disciplined approach to
risk selection, combined with the actions taken over the past year
to strengthen our reserve position, are showing tangible results.
As we move forward, we remain focused on delivering value to
shareholders as we take advantage of the attractive E&S
underwriting environment while closely managing our expenses."
- E&S Segment
Highlights:
- For the first
quarter of 2025, the segment's gross written premium was largely
flat to the comparable quarter last year.
- Renewal rate
increases across the segment were 7.8% during the quarter.
- The segment
continued to experience strong submission growth, with the 6%
growth in renewal submissions exceeding 2024 levels.
- There was de
minimis favorable reserve development during the quarter.
- Specialty
Admitted Insurance Segment Highlights:
- Gross written premium for the fronting and program business
declined 21.3% compared to the prior year quarter, as the Company
manages this segment to retain minimal risk. This excludes the
impact of our large workers’ compensation program and Individual
Risk Workers’ Compensation book, which were non-renewed in the
second quarter of 2023 and sold via a renewal rights transaction in
the third quarter of 2023, respectively. Overall, premium declined
30.7%
- While the
fronting business of the segment is transactional in nature, the
Company remains focused on managing its expenses in this segment
over the course of the calendar year.
- There was de
minimis prior year reserve movement during the quarter.
First Quarter 2025 Operating
Results
- Gross written premium of $294.4 million, consisting of the
following:
|
Three Months EndedMarch 31, |
|
($ in
thousands) |
2025 |
|
2024 |
|
% Change |
Excess and Surplus Lines |
$ |
213,243 |
|
$ |
213,691 |
|
0 |
% |
Specialty Admitted
Insurance |
|
81,118 |
|
|
117,119 |
|
(31 |
)% |
|
$ |
294,361 |
|
$ |
330,810 |
|
(11 |
)% |
|
|
|
|
|
|
|
|
- Net written premium of $128.0 million, consisting of the
following:
|
Three Months EndedMarch 31, |
|
|
($ in
thousands) |
2025 |
|
2024 |
|
% Change |
|
Excess and Surplus Lines |
$ |
115,079 |
|
$ |
117,425 |
|
(2 |
)% |
Specialty Admitted
Insurance |
|
12,877 |
|
|
20,747 |
|
(38 |
)% |
|
$ |
127,956 |
|
$ |
138,172 |
|
(7 |
)% |
|
|
|
|
|
|
|
|
|
- Net earned premium of $151.9 million, consisting of the
following:
|
Three Months EndedMarch 31, |
|
|
($ in
thousands) |
2025 |
|
2024 |
|
% Change |
|
Excess and Surplus Lines |
$ |
137,028 |
|
$ |
145,623 |
|
(6 |
)% |
Specialty Admitted
Insurance |
|
14,874 |
|
|
26,068 |
|
(43 |
)% |
|
$ |
151,902 |
|
$ |
171,691 |
|
(12 |
)% |
|
|
|
|
|
|
|
|
|
-
As cited above, the first quarter of 2025 included de minimis
favorable reserve development in each of the two insurance
segments. There remains $116.2 million of aggregate limit on the
two E&S segment retroactive reinsurance structures which cover
the majority of James River’s E&S segment net reserves for
James River’s E&S segment for accident years 2010 -2023.
-
Pre-tax favorable (unfavorable) reserve development by segment on
business not subject to retroactive reinsurance accounting for loss
portfolio transfers was as follows:
|
Three Months EndedMarch 31, |
($ in
thousands) |
2025 |
|
2024 |
Excess and Surplus Lines |
$ |
10 |
|
$ |
(40 |
) |
Specialty Admitted
Insurance |
|
121 |
|
|
438 |
|
|
$ |
131 |
|
$ |
398 |
|
|
|
|
|
|
|
|
-
Retroactive benefits of $1.9 million were recorded in loss and loss
adjustment expenses during the first quarter and the total deferred
retroactive reinsurance gain on the Balance Sheet is $56.0 million
as of March 31, 2025.
-
The consolidated expense ratio was 32.7% for the first quarter of
2025, which was an increase from 28.9% in the prior year quarter.
The expense ratio increase was primarily driven by higher
compensation expenses on lower net earned premium.
Investment ResultsNet
investment income for the first quarter of 2025 was $20.0 million,
a decline of 11.6% compared to $22.6 million in the prior year
quarter. The comparable decline in income was primarily due to a
smaller asset base following the funding of retroactive reinsurance
structures for the E&S segment which were purchased in the
second half of 2024.
The Company’s net investment income consisted of
the following:
|
Three Months EndedMarch 31, |
|
|
($ in
thousands) |
2025 |
|
2024 |
|
% Change |
Private Investments |
|
200 |
|
|
(145 |
) |
|
NM |
|
All Other Investments |
|
19,808 |
|
|
22,777 |
|
|
(13 |
)% |
Total Net Investment
Income |
$ |
20,008 |
|
$ |
22,632 |
|
|
(12 |
)% |
|
|
|
|
|
|
|
|
|
|
The Company’s annualized gross investment yield
on average fixed maturity, bank loan and equity securities for the
three months ended March 31, 2025 was 4.6% (versus 4.8% for the
three months ended March 31, 2024).
Net realized and unrealized losses on
investments of ($1.4) million for the three months ended March 31,
2025 compared to net realized and unrealized gains on investments
of $4.6 million in the prior year quarter. The majority of the
realized and unrealized losses during the quarter were related to
realized losses on sales in our bank loan portfolio, partially
offset by increases in the fair value of our preferred stock
portfolio.
Discontinued Operations
In connection with the process outlined in the Stock Purchase
Agreement, and as previously disclosed, the buyer of JRG Re claimed
a $54.1 million downward adjustment to the closing purchase price,
which the Company disputed. As per the Stock Purchase Agreement,
the disputed items (totaling $54.1 million) were submitted to an
independent accounting firm for final resolution. On April 18,
2025, the independent accounting firm issued its final
determination which resulted in a small downward adjustment to the
closing purchase price of $0.5 million. The determination by the
independent accounting firm is final and binding with regards to
the purchase price.
Capital Management
The Company announced that its Board of Directors declared a
cash dividend of $0.01 per common share. This dividend is payable
on Monday, June 30, 2025 to all shareholders of record on Monday,
June 9, 2025.
Tangible Common Equity Per Share
Shareholders' equity of $484.5 million at March
31, 2025 increased 5.1% compared to shareholders' equity of $460.9
million at December 31, 2024. Tangible common equity3 per share of
$7.11 at March 31, 2025 increased 6.6% compared to tangible
common equity per share of $6.67 at December 31, 2024, due to net
income from continuing operations, partially offset by a small net
loss from discontinued operations. Other comprehensive income
benefited by $14.3 million during the first quarter of 2025,
improving AOCI to ($55.7) million due to a decline in interest
rates.
Conference Call
James River will hold a conference call to
discuss its first quarter results tomorrow, May 6, 2025 at 8:00
a.m. Eastern Time. Investors may access the conference call by
dialing (800) 715-9871, Conference ID 8501569, or via the internet
by visiting www.jrvrgroup.com and clicking on the “Investor
Relations” link. A webcast replay of the call will be available by
visiting the company website.
Forward-Looking Statements
This press release contains forward-looking
statements as that term is defined in the Private Securities
Litigation Reform Act of 1995. In some cases, such forward-looking
statements may be identified by terms such as believe, expect,
seek, may, will, should, intend, project, anticipate, plan,
estimate, guidance or similar words. Forward-looking statements
involve risks and uncertainties that could cause actual results to
differ materially from those in the forward-looking statements.
Although it is not possible to identify all of these risks and
uncertainties, they include, among others, the following: the
inherent uncertainty of estimating reserves and the possibility
that incurred losses may be greater than our estimate used to
compute loss and loss adjustment expense reserves; inaccurate
estimates and judgments in our risk management may expose us to
greater risks than intended; downgrades in the financial strength
rating or outlook of our regulated insurance subsidiaries impacting
our competitive position and ability to attract and retain
insurance business that our subsidiaries write and ultimately our
financial condition; the potential loss of key members of our
management team or key employees, and our ability to attract and
retain personnel; adverse economic and competitive factors
resulting in the sale of fewer policies than expected or an
increase in the frequency or severity of claims, or both; the
impact of a higher than expected inflationary environment on our
reserves, loss adjustment expenses, the values of our investments
and investment returns, and our compensation expenses; exposure to
credit risk, interest rate risk and other market risk in our
investment portfolio and our reinsurers; reliance on a select group
of brokers and agents for a significant portion of our business and
the impact of our potential failure to maintain such relationships;
reliance on a select group of customers for a significant portion
of our business and the impact of our potential failure to
maintain, or decision to terminate, such relationships; our ability
to obtain insurance and reinsurance coverage at prices and on terms
that allow us to transfer risk, adequately protect our Company
against financial loss and that supports our growth plans; losses
resulting from reinsurance counterparties failing to pay us on
reinsurance claims, insurance companies with whom we have a
fronting arrangement failing to pay us for claims, or a former
customer with whom we have an indemnification arrangement failing
to perform its reimbursement obligations, and our potential
inability to demand or maintain adequate collateral to mitigate
such risks; the inherent uncertainty of estimating reinsurance
recoverable on unpaid losses and the possibility that reinsurance
may be less than our estimate of reinsurance recoverable on unpaid
losses; inadequacy of premiums we charge to compensate us for our
losses incurred; changes in laws or government regulation,
including tax or insurance laws and regulations; changes in U.S.
tax laws (including associated regulations) and the interpretation
of certain provisions applicable to insurance/reinsurance
businesses with U.S. and non-U.S. operations, which may be
retroactive and could have a significant effect on us including,
among other things, by potentially increasing our tax rate, as well
as on our shareholders; in the event we did not qualify for the
insurance company exception to the passive foreign investment
company (“PFIC”) rules and were therefore considered a PFIC, there
could be material adverse tax consequences to an investor that is
subject to U.S. federal income taxation; the Company or its foreign
subsidiary becoming subject to U.S. federal income taxation; a
failure of any of the loss limitations or exclusions we utilize to
shield us from unanticipated financial losses or legal exposures,
or other liabilities; losses from catastrophic events, such as
natural disasters and terrorist acts, which substantially exceed
our expectations and/or exceed the amount of reinsurance we have
purchased to protect us from such events; potential effects on our
business of emerging claim and coverage issues; the potential
impact of internal or external fraud, operational errors, systems
malfunctions or cyber security incidents; our ability to manage our
growth effectively; failure to maintain effective internal controls
in accordance with the Sarbanes-Oxley Act of 2002, as amended;
changes in our financial condition, regulations or other factors
that may restrict our subsidiaries’ ability to pay us dividends;
and an adverse result in any litigation or legal proceedings we are
or may become subject to. Additional information about these risks
and uncertainties, as well as others that may cause actual results
to differ materially from those in the forward-looking statements,
is contained in our filings with the U.S. Securities and Exchange
Commission ("SEC"), including our most recently filed Annual Report
on Form 10-K. These forward-looking statements speak only as of the
date of this release and the Company does not undertake any
obligation to update or revise any forward-looking information to
reflect changes in assumptions, the occurrence of unanticipated
events, or otherwise.
Non-GAAP Financial Measures
In presenting James River Group Holdings, Ltd.’s
results, management has included financial measures that are not
calculated under standards or rules that comprise accounting
principles generally accepted in the United States (“GAAP”). Such
measures, including underwriting (loss) profit, adjusted net
operating (loss) income, tangible equity, tangible common equity,
and adjusted net operating return on tangible equity (which is
calculated as annualized adjusted net operating income divided by
the average quarterly tangible equity balances in the respective
period), are referred to as non-GAAP measures. These non-GAAP
measures may be defined or calculated differently by other
companies. These measures should not be viewed as a substitute for
those measures determined in accordance with GAAP. Reconciliations
of such measures to the most comparable GAAP figures are included
at the end of this press release.
About James River Group Holdings,
Ltd.
James River Group Holdings, Ltd. is a
Bermuda-based insurance holding company that owns and operates a
group of specialty insurance companies. The Company operates in two
specialty property-casualty insurance segments: Excess and Surplus
Lines and Specialty Admitted Insurance. Each of the Company’s
regulated insurance subsidiaries are rated “A-” (Excellent) by A.M.
Best Company.
Visit James River Group Holdings, Ltd. on the
web at www.jrvrgroup.com
For more information
contact:
Zachary ShytleSenior Analyst, Investments and
Investor
Relations980-249-6848InvestorRelations@james-river-group.com
|
James River Group Holdings, Ltd. and
SubsidiariesCondensed Consolidated Balance Sheet
Data (Unaudited) |
|
($ in thousands,
except for share data) |
March 31, 2025 |
|
December 31, 2024 |
ASSETS |
|
|
|
Invested assets: |
|
|
|
Fixed maturity securities, available-for-sale, at fair value |
$ |
1,259,627 |
|
$ |
1,189,733 |
Equity securities, at fair
value |
|
87,746 |
|
|
86,479 |
Bank loan participations, at
fair value |
|
144,014 |
|
|
142,410 |
Short-term investments |
|
79,091 |
|
|
97,074 |
Other invested assets |
|
52,768 |
|
|
36,700 |
Total invested assets |
|
1,623,246 |
|
|
1,552,396 |
|
|
|
|
Cash and cash equivalents |
|
279,427 |
|
|
362,345 |
Restricted cash equivalents
(a) |
|
29,012 |
|
|
28,705 |
Accrued investment income |
|
10,567 |
|
|
10,534 |
Premiums receivable and
agents’ balances, net |
|
205,965 |
|
|
243,882 |
Reinsurance recoverable on
unpaid losses, net |
|
1,984,292 |
|
|
1,996,913 |
Reinsurance recoverable on
paid losses |
|
127,627 |
|
|
101,210 |
Deferred policy acquisition
costs |
|
27,844 |
|
|
30,175 |
Goodwill and intangible
assets |
|
214,190 |
|
|
214,281 |
Other assets |
|
446,845 |
|
|
466,635 |
Total assets |
$ |
4,949,015 |
|
$ |
5,007,076 |
|
|
|
|
LIABILITIES AND
SHAREHOLDERS’ EQUITY |
|
|
|
Reserve for losses and loss
adjustment expenses |
$ |
3,081,540 |
|
$ |
3,084,406 |
Unearned premiums |
|
526,506 |
|
|
572,034 |
Funds held (a) |
|
25,157 |
|
|
25,157 |
Deferred reinsurance gain |
|
56,042 |
|
|
57,970 |
Senior debt |
|
225,800 |
|
|
200,800 |
Junior subordinated debt |
|
104,055 |
|
|
104,055 |
Accrued expenses |
|
39,196 |
|
|
53,178 |
Other liabilities |
|
273,124 |
|
|
315,446 |
Total liabilities |
|
4,331,420 |
|
|
4,413,046 |
|
|
|
|
Series A redeemable preferred
shares |
|
133,115 |
|
|
133,115 |
Total shareholders’
equity |
|
484,480 |
|
|
460,915 |
Total liabilities, Series A
redeemable preferred shares, and shareholders’ equity |
$ |
4,949,015 |
|
$ |
5,007,076 |
|
|
|
|
Tangible equity (b) |
$ |
459,447 |
|
$ |
437,719 |
Tangible equity per share
(b) |
$ |
7.73 |
|
$ |
7.40 |
Tangible common equity per
share (b) |
$ |
7.11 |
|
$ |
6.67 |
Shareholders' equity per
share |
$ |
10.56 |
|
$ |
10.10 |
Common shares outstanding |
|
45,892,706 |
|
|
45,644,318 |
|
|
|
|
(a) Restricted cash equivalents and the funds held liability
includes funds posted by the Company to a trust account for the
benefit of a third party administrator handling the claims on the
Rasier commercial auto policies in run-off. Such funds held in
trust secure the Company's obligations to reimburse the
administrator for claims payments, and are primarily sourced from
the collateral posted to the Company by Rasier and its affiliates
to support their obligations under the indemnity agreements and the
loss portfolio transfer reinsurance agreement with the
Company. |
(b) See “Reconciliation of
Non-GAAP Measures” |
|
|
|
|
James River Group Holdings, Ltd. and
SubsidiariesCondensed Consolidated Income
Statement Data (Unaudited) |
|
|
Three Months EndedMarch 31, |
($ in thousands, except for share data) |
|
2025 |
|
|
|
2024 |
|
REVENUES |
|
|
|
Gross written premiums |
$ |
294,361 |
|
|
$ |
330,810 |
|
Net written premiums |
|
127,956 |
|
|
|
138,172 |
|
|
|
|
|
Net earned premiums |
|
151,902 |
|
|
|
171,691 |
|
Net investment income |
|
20,008 |
|
|
|
22,632 |
|
Net realized and unrealized
(losses) gains on investments |
|
(1,371 |
) |
|
|
4,583 |
|
Other income |
|
1,750 |
|
|
|
2,221 |
|
Total revenues |
|
172,289 |
|
|
|
201,127 |
|
|
|
|
|
EXPENSES |
|
|
|
Losses and loss adjustment
expenses (a) |
|
99,525 |
|
|
|
110,049 |
|
Other operating expenses |
|
50,560 |
|
|
|
50,810 |
|
Other expenses |
|
563 |
|
|
|
732 |
|
Interest expense |
|
5,541 |
|
|
|
6,485 |
|
Intangible asset amortization
and impairment |
|
91 |
|
|
|
91 |
|
Total expenses |
|
156,280 |
|
|
|
168,167 |
|
Income from continuing
operations before income taxes |
|
16,009 |
|
|
|
32,960 |
|
Income tax expense on
continuing operations |
|
5,021 |
|
|
|
9,452 |
|
Net income from continuing
operations |
|
10,988 |
|
|
|
23,508 |
|
Net loss from discontinued
operations |
|
(1,414 |
) |
|
|
(8,105 |
) |
NET
INCOME |
|
9,574 |
|
|
|
15,403 |
|
Dividends on Series A
preferred shares |
|
(1,969 |
) |
|
|
(2,625 |
) |
NET INCOME AVAILABLE
TO COMMON SHAREHOLDERS |
$ |
7,605 |
|
|
$ |
12,778 |
|
ADJUSTED NET OPERATING
INCOME (b) |
$ |
9,102 |
|
|
$ |
14,832 |
|
|
|
|
|
INCOME (LOSS) PER
COMMON SHARE |
|
|
|
Basic |
|
|
|
Continuing operations |
$ |
0.20 |
|
|
$ |
0.55 |
|
Discontinued operations |
$ |
(0.03 |
) |
|
$ |
(0.21 |
) |
|
$ |
0.17 |
|
|
$ |
0.34 |
|
Diluted |
|
|
|
Continuing operations (c) |
$ |
0.18 |
|
|
$ |
0.53 |
|
Discontinued operations |
$ |
(0.02 |
) |
|
$ |
(0.18 |
) |
|
$ |
0.16 |
|
|
$ |
0.35 |
|
|
|
|
|
ADJUSTED NET OPERATING
INCOME PER COMMON SHARE |
|
|
|
Basic |
$ |
0.20 |
|
|
$ |
0.39 |
|
Diluted (c) |
$ |
0.19 |
|
|
$ |
0.39 |
|
|
|
|
|
Weighted-average common shares
outstanding: |
|
|
|
Basic |
|
45,803,501 |
|
|
|
37,733,710 |
|
Diluted |
|
59,659,075 |
|
|
|
44,638,969 |
|
Cash dividends declared per
common share |
$ |
0.01 |
|
|
$ |
0.05 |
|
|
|
|
|
Ratios: |
|
|
|
Loss ratio |
|
66.8 |
% |
|
|
66.4 |
% |
Expense ratio (d) |
|
32.7 |
% |
|
|
28.9 |
% |
Combined ratio |
|
99.5 |
% |
|
|
95.3 |
% |
Accident year loss ratio
(e) |
|
65.5 |
% |
|
|
66.7 |
% |
|
|
|
|
(a) Losses and loss adjustment expenses include benefits of $1.9
million and $4.0 million for deferred retroactive reinsurance gains
(benefits) for the three months ended March 31, 2025 and 2024,
respectively. |
(b) See "Reconciliation of Non-GAAP Measures". |
(c) The outstanding Series A preferred shares were dilutive in both
periods. Dividends on the Series A preferred shares were added back
to the numerator of the calculation and common shares from an
assumed conversion of the Series A preferred shares were included
in the denominator. |
(d) Calculated with a numerator comprising other operating expenses
less gross fee income (in specific instances when the Company is
not retaining insurance risk) included in “Other income” in our
Condensed Consolidated Income Statements of $0.8 million and $1.3
million for the three months ended March 31, 2025 and 2024,
respectively. |
(e) Ratio of losses and loss adjustment expenses for the current
accident year, excluding development on prior accident year
reserves, to net earned premiums for the current year (excluding
net earned premium adjustments on certain reinsurance treaties with
reinstatement premiums associated with prior years). |
|
James River Group Holdings, Ltd. and
SubsidiariesSegment Results |
|
EXCESS
AND SURPLUS LINES |
|
|
Three Months EndedMarch 31, |
|
|
($ in
thousands) |
|
2025 |
|
|
|
2024 |
|
|
% Change |
Gross written premiums |
$ |
213,243 |
|
|
$ |
213,691 |
|
|
(0.2 |
)% |
Net written premiums |
$ |
115,079 |
|
|
$ |
117,425 |
|
|
(2.0 |
)% |
|
|
|
|
|
|
Net earned premiums |
$ |
137,028 |
|
|
$ |
145,623 |
|
|
(5.9 |
)% |
Losses and loss adjustment
expenses excluding retroactive reinsurance |
|
(88,804 |
) |
|
|
(93,605 |
) |
|
(5.1 |
)% |
Underwriting expenses |
|
(36,566 |
) |
|
|
(33,527 |
) |
|
9.1 |
% |
Underwriting profit (a) |
$ |
11,658 |
|
|
$ |
18,491 |
|
|
(37.0 |
)% |
|
|
|
|
|
|
Ratios: |
|
|
|
|
|
Loss ratio |
|
64.8 |
% |
|
|
64.3 |
% |
|
|
Expense ratio |
|
26.7 |
% |
|
|
23.0 |
% |
|
|
Combined ratio |
|
91.5 |
% |
|
|
87.3 |
% |
|
|
Accident year loss ratio
(b) |
|
63.4 |
% |
|
|
64.3 |
% |
|
|
|
|
|
|
|
|
(a) See
"Reconciliation of Non-GAAP Measures". |
(b) Ratio of
losses and loss adjustment expenses for the current accident year,
excluding development on prior accident year reserves, to net
earned premiums for the current year (excluding net earned premium
adjustments on certain reinsurance treaties with reinstatement
premiums associated with prior years). |
|
|
SPECIALTY
ADMITTED INSURANCE |
|
|
|
|
Three Months EndedMarch 31, |
|
|
|
($ in thousands) |
|
2025 |
|
|
|
2024 |
|
|
% Change |
|
Gross written premiums |
$ |
81,118 |
|
|
$ |
117,119 |
|
|
(30.7 |
)% |
Net written premiums |
$ |
12,877 |
|
|
$ |
20,747 |
|
|
(37.9 |
)% |
|
|
|
|
|
|
|
Net earned premiums |
$ |
14,874 |
|
|
$ |
26,068 |
|
|
(42.9 |
)% |
Losses and loss adjustment
expenses |
|
(12,649 |
) |
|
|
(20,446 |
) |
|
(38.1 |
)% |
Underwriting expenses |
|
(2,531 |
) |
|
|
(4,836 |
) |
|
(47.7 |
)% |
Underwriting profit (a),
(b) |
$ |
(306 |
) |
|
$ |
786 |
|
|
— |
|
|
|
|
|
|
|
|
Ratios: |
|
|
|
|
|
|
Loss ratio |
|
85.0 |
% |
|
|
78.4 |
% |
|
|
|
Expense ratio |
|
17.1 |
% |
|
|
18.6 |
% |
|
|
|
Combined ratio |
|
102.1 |
% |
|
|
97.0 |
% |
|
|
|
Accident year loss ratio |
|
85.9 |
% |
|
|
80.1 |
% |
|
|
|
|
|
|
|
|
|
|
(a) See "Reconciliation of
Non-GAAP Measures". |
|
|
|
|
|
|
(b) Underwriting results for the three months ended March 31,
2025 and 2024 include gross fee income of $4.3 million and $5.3
million, respectively. |
|
|
|
Underwriting Performance Ratios
The following table provides the underwriting
performance ratios of the Company's continuing operations inclusive
of the business subject to retroactive reinsurance accounting.
There is no economic impact to the Company over the life of a
retroactive reinsurance contract so long as any additional losses
subject to the contract are within the limit of the contract and
the counterparty performs under the contract. Retroactive
reinsurance accounting is not indicative of our current and ongoing
operations. Management believes that providing loss ratios and
combined ratios on business not subject to retroactive reinsurance
accounting gives the users of our financial statements useful
information in evaluating our current and ongoing operations.
|
Three Months EndedMarch 31, |
|
2025 |
|
2024 |
Excess and Surplus
Lines: |
|
|
|
Loss Ratio |
64.8 |
% |
|
64.3 |
% |
Impact of retroactive
reinsurance |
(1.4 |
)% |
|
(2.7 |
)% |
Loss Ratio including impact of
retroactive reinsurance |
63.4 |
% |
|
61.6 |
% |
|
|
|
|
Combined Ratio |
91.5 |
% |
|
87.3 |
% |
Impact of retroactive
reinsurance |
(1.4 |
)% |
|
(2.7 |
)% |
Combined Ratio including
impact of retroactive reinsurance |
90.1 |
% |
|
84.6 |
% |
|
|
|
|
Consolidated: |
|
|
|
Loss Ratio |
66.8 |
% |
|
66.4 |
% |
Impact of retroactive
reinsurance |
(1.3 |
)% |
|
(2.3 |
)% |
Loss Ratio including impact of
retroactive reinsurance |
65.5 |
% |
|
64.1 |
% |
|
|
|
|
Combined Ratio |
99.5 |
% |
|
95.3 |
% |
Impact of retroactive
reinsurance |
(1.3 |
)% |
|
(2.3 |
)% |
Combined Ratio including
impact of retroactive reinsurance |
98.2 |
% |
|
93.0 |
% |
|
|
|
|
|
|
RECONCILIATION OF NON-GAAP MEASURES
Underwriting Profit
The following table reconciles the underwriting
profit by individual operating segment and for the entire Company
to consolidated income from continuing operations before taxes. We
believe that the disclosure of underwriting profit by individual
segment and of the Company as a whole is useful to investors,
analysts, rating agencies and other users of our financial
information in evaluating our performance because our objective is
to consistently earn underwriting profits. We evaluate the
performance of our segments and allocate resources based primarily
on underwriting profit. We define underwriting profit as net earned
premiums and gross fee income (in specific instances when the
Company is not retaining insurance risk) less losses and loss
adjustment expenses on business from continuing operations not
subject to retroactive reinsurance accounting and other operating
expenses. Other operating expenses include the underwriting,
acquisition, and insurance expenses of the operating segments and,
for consolidated underwriting profit, the expenses of the Corporate
and Other segment. Our definition of underwriting profit may not be
comparable to that of other companies.
|
Three Months EndedMarch 31, |
($ in thousands) |
|
2025 |
|
|
|
2024 |
|
Underwriting profit of the
operating segments: |
|
|
|
Excess and Surplus Lines |
$ |
11,658 |
|
|
$ |
18,491 |
|
Specialty Admitted Insurance |
|
(306 |
) |
|
|
786 |
|
Total underwriting profit of
operating segments |
|
11,352 |
|
|
|
19,277 |
|
Other operating expenses of
the Corporate and Other segment |
|
(10,631 |
) |
|
|
(11,137 |
) |
Underwriting profit (a) |
|
721 |
|
|
|
8,140 |
|
Losses and loss adjustment
expenses - retroactive reinsurance |
|
1,928 |
|
|
|
4,002 |
|
Net investment income |
|
20,008 |
|
|
|
22,632 |
|
Net realized and unrealized
gains on investments |
|
(1,371 |
) |
|
|
4,583 |
|
Other income (expense) |
|
355 |
|
|
|
179 |
|
Interest expense |
|
(5,541 |
) |
|
|
(6,485 |
) |
Amortization of intangible
assets |
|
(91 |
) |
|
|
(91 |
) |
Income from continuing
operations before taxes |
$ |
16,009 |
|
|
$ |
32,960 |
|
|
|
|
|
(a) Included in underwriting results for the three months ended
March 31, 2025 and 2024 is gross fee income of $4.3 million
and $5.3 million, respectively. |
|
Adjusted Net Operating
Income
We define adjusted net operating income as
income available to common shareholders excluding a) income (loss)
from discontinued operations, b) the impact of retroactive
reinsurance accounting, c) net realized and unrealized gains
(losses) on investments, d) certain non-operating expenses such as
professional service fees related to certain lawsuits, various
strategic initiatives, and the filing of registration statements
for the offering of securities, e) severance costs associated with
terminated employees, and f) deemed dividends recorded with the
amendment of the Series A Preferred Shares. Adjusted net operating
income should not be viewed as a substitute for net income
calculated in accordance with GAAP, and our definition of adjusted
net operating income may not be comparable to that of other
companies.
Our income available to common shareholders
reconciles to our adjusted net operating income as follows:
|
Three Months Ended March 31, |
|
|
2025 |
|
|
|
2024 |
|
($ in
thousands) |
IncomeBeforeTaxes |
|
NetIncome |
|
IncomeBeforeTaxes |
|
NetIncome |
Income available to common shareholders |
$ |
12,626 |
|
|
$ |
7,605 |
|
|
$ |
22,230 |
|
|
$ |
12,778 |
|
Loss from discontinued
operations |
|
1,414 |
|
|
|
1,414 |
|
|
|
8,105 |
|
|
|
8,105 |
|
Losses and loss adjustment
expenses - retroactive reinsurance |
|
(1,928 |
) |
|
|
(1,523 |
) |
|
|
(4,002 |
) |
|
|
(3,162 |
) |
Net realized and unrealized
investment losses (gains) |
|
1,371 |
|
|
|
1,083 |
|
|
|
(4,583 |
) |
|
|
(3,621 |
) |
Other expenses |
|
563 |
|
|
|
523 |
|
|
|
732 |
|
|
|
732 |
|
Adjusted net operating
income |
$ |
14,046 |
|
|
$ |
9,102 |
|
|
$ |
22,482 |
|
|
$ |
14,832 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tangible Equity (per Share) and Tangible
Common Equity (per Share)
We define tangible equity as shareholders' equity plus mezzanine
Series A Preferred Shares and the deferred retroactive reinsurance
gain less goodwill and intangible assets, net of amortization.
Tangible equity per share represents tangible equity divided by the
sum of total common shares outstanding plus the common shares
resulting from an assumed conversion of the outstanding Series A
Preferred Shares into common shares (at the conversion price
effective as of the last day of the applicable period). We define
tangible common equity as tangible equity less mezzanine Series A
Preferred Shares and tangible common equity per share represents
tangible common equity divided by the total common shares
outstanding. Our definitions of tangible equity and tangible equity
per share may not be comparable to that of other companies, and
they should not be viewed as a substitute for shareholders’ equity
and shareholders’ equity per share calculated in accordance with
GAAP. We use tangible equity and tangible common equity internally
to evaluate the strength of our balance sheet and to compare
returns relative to this measure. The following table reconciles
shareholders’ equity to tangible equity and tangible common equity
for March 31, 2025, December 31, 2024, March 31, 2024,
and December 31, 2023.
|
March 31, 2025 |
|
December 31, 2024 |
|
March 31, 2024 |
|
December 31, 2023 |
($ in thousands,
except for share data) |
|
|
|
|
|
|
|
Shareholders' equity |
$ |
484,480 |
|
|
$ |
460,915 |
|
|
$ |
539,537 |
|
|
$ |
534,621 |
|
Plus: Series A redeemable
preferred shares |
|
133,115 |
|
|
|
133,115 |
|
|
|
144,898 |
|
|
|
144,898 |
|
Plus: Deferred reinsurance
gain |
|
56,042 |
|
|
|
57,970 |
|
|
|
16,731 |
|
|
|
20,733 |
|
Less: Goodwill and intangible
assets |
|
214,190 |
|
|
|
214,281 |
|
|
|
214,553 |
|
|
|
214,644 |
|
Tangible equity |
$ |
459,447 |
|
|
$ |
437,719 |
|
|
$ |
486,613 |
|
|
$ |
485,608 |
|
Less: Series A redeemable
preferred shares |
|
133,115 |
|
|
|
133,115 |
|
|
|
144,898 |
|
|
|
144,898 |
|
Tangible common equity |
$ |
326,332 |
|
|
$ |
304,604 |
|
|
$ |
341,715 |
|
|
$ |
340,710 |
|
|
|
|
|
|
|
|
|
Common shares outstanding |
|
45,892,706 |
|
|
|
45,644,318 |
|
|
|
37,822,340 |
|
|
|
37,641,563 |
|
Common shares from assumed
conversion of Series A preferred shares |
|
13,521,635 |
|
|
|
13,521,635 |
|
|
|
6,750,567 |
|
|
|
5,971,184 |
|
Common shares outstanding
after assumed conversion of Series A preferred shares |
|
59,414,341 |
|
|
|
59,165,953 |
|
|
|
44,572,907 |
|
|
|
43,612,747 |
|
|
|
|
|
|
|
|
|
Equity per share: |
|
|
|
|
|
|
|
Shareholders' equity |
$ |
10.56 |
|
|
$ |
10.10 |
|
|
$ |
14.27 |
|
|
$ |
14.20 |
|
Tangible equity |
$ |
7.73 |
|
|
$ |
7.40 |
|
|
$ |
10.92 |
|
|
$ |
11.13 |
|
Tangible common equity |
$ |
7.11 |
|
|
$ |
6.67 |
|
|
$ |
9.03 |
|
|
$ |
9.05 |
|
_______________1 Adjusted net operating income, tangible common
equity and adjusted net operating return on tangible common equity
are non-GAAP financial measures. See “Non-GAAP Financial Measures”
and “Reconciliation of Non-GAAP Financial Measures” at the end of
this press release.2 The Company closed the sale of JRG Reinsurance
Company Ltd. on April 16, 2024. The full financials for our former
Casualty Reinsurance segment have been classified to discontinued
operations for all periods and includes the final adjustment
determination to the closing purchase price pursuant to the Stock
Purchase Agreement.3 Tangible common equity is a non-GAAP financial
measures. See “Non-GAAP Financial Measures” and “Reconciliation of
Non-GAAP Financial Measures” at the end of this press release.
James River (NASDAQ:JRVR)
Historical Stock Chart
From Jun 2025 to Jul 2025
James River (NASDAQ:JRVR)
Historical Stock Chart
From Jul 2024 to Jul 2025